18 results
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals, Inc.
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same
8-K
EX-3.1
CRNX
Crinetics Pharmaceuticals, Inc.
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
as a director of the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality, stock ownership and trading … reasonably concluded that there may be a conflict of interest or position on any significant issue between the Corporation and Indemnitee in the conduct
8-K
EX-99.1
dge7f7e207vqlc5gi
29 Jul 21
Stock Purchase Agreement
4:15pm
10-K
8umfewit4m29nc511x
13 Mar 19
Annual report
4:06pm
8-K
EX-3.2
g18epl97l5vv8pwy
20 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
khl85ap7lup 0khp
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
a0sspm
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-3.4
y41d0yraw5 i0
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.9
d5z08j4w5inz67zk
9 Jul 18
IPO registration (amended)
6:10am
S-1
5xh 2w4a2q1v5yvl21
22 Jun 18
IPO registration
4:07pm
DRS/A
813rzymw
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
na5ihx x40
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next